Literature DB >> 32592821

Diverse effects of different Akkermansia muciniphila genotypes on Brown adipose tissue inflammation and whitening in a high-fat-diet murine model.

Lulu Deng1, Zihao Ou2, Dongquan Huang3, Chong Li4, Zhi Lu5, Wanting Liu6, Feifan Wu7, Caihong Nong8, Jie Gao9, Yongzheng Peng10.   

Abstract

BACKGROUND: The purpose of this study was to investigate the differences in the metabolic protective effects of Akkermansia muciniphila (A.muciniphila) genotypes on high-fat diet mice and explore possible mechanisms.
METHODS: Male C57BL/6 mice were randomly divided into 6 groups, including high-fat diet (HFD)+ A. muciniphila I/II/PBS group, normal control diet (NCD)+ A. muciniphila I/II/PBS group, respectively. Dietary intervention and A. muciniphila gavage were performed simultaneously. Blood glucose and lipid metabolism, brown adipose morphology and activities, and intestinal barrier function were examined after the mice were sacrificed.
RESULTS: A.muciniphila gavage improved the impaired glucose tolerance, hyperlipidemia and liver steatosis in HFD mice, and that A. muciniphila II (Amuc_GP25) was not as effective as A. muciniphila I (Amuc_GP01). This phenomenon might be because Amuc_GP01 intervention significantly inhibited brown adipose tissue whitening and inflammation induced by HFD, by repairing the intestinal barrier and relieving endotoxemia. Amuc_GP25 did not display the same results as Amuc_GP01 in HFD mice but had stronger effects in the NCD mice.
CONCLUSIONS: This study reveals the distinct functions of different A. muciniphila genotypes on diet-induced obesity, suggesting that different A. muciniphila genotypes may affect pathological conditions differently through distinct action pathways.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akkermansia muciniphila; Genotype; High-fat-diet; brown adipose tissue

Mesh:

Year:  2020        PMID: 32592821     DOI: 10.1016/j.micpath.2020.104353

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

Review 1.  The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment.

Authors:  Binbin Zhang; Jianan Zhao; Minjie Jiang; Dandan Peng; Xiaobing Dou; Yu Song; Junping Shi
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

2.  Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?

Authors:  Juan Yan; Lili Sheng; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury.

Authors:  Shahrbanoo Keshavarz Azizi Raftar; Fatemeh Ashrafian; Abbas Yadegar; Arezou Lari; Hamid Reza Moradi; Arefeh Shahriary; Masoumeh Azimirad; Helia Alavifard; Zhaleh Mohsenifar; Mehdi Davari; Farzam Vaziri; Arfa Moshiri; Seyed Davar Siadat; Mohammad Reza Zali
Journal:  Microbiol Spectr       Date:  2021-09-22

Review 4.  Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics.

Authors:  Jonathan Breton; Marie Galmiche; Pierre Déchelotte
Journal:  Microorganisms       Date:  2022-02-16

5.  Mechanism of Action of Shenerjiangzhi Formulation on Hyperlipidemia Induced by Consumption of a High-Fat Diet in Rats Using Network Pharmacology and Analyses of the Gut Microbiota.

Authors:  Shuang Zhang; Yu Wang; Fang Lu; Shadi A D Mohammed; Hanxing Liu; Song Ding; Shu-Min Liu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

Review 6.  Probiotic Mechanisms Affecting Glucose Homeostasis: A Scoping Review.

Authors:  Maša Pintarič; Tomaž Langerholc
Journal:  Life (Basel)       Date:  2022-08-03

Review 7.  Akkermansia muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review.

Authors:  Jumana Nabil Abuqwider; Gianluigi Mauriello; Mohammad Altamimi
Journal:  Microorganisms       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.